Intraocular use of rituximab
A.S. Kitzmann(Mayo Clinic), J. Douglas Cameron(Hennepin County), Keith H. Baratz(Mayo Clinic in Arizona), Diva R. Salomão(Mayo Clinic in Arizona), Patrick B. Johnston(Mayo Clinic in Arizona), José S. Pulido(Wills Eye Hospital), Brian Patrick O’Neill(Henry Ford Health System), Ronald J. Marler(Mayo Clinic in Arizona), Brian G. Mohney(Mayo Clinic), Laura Dixon(Mayo Clinic in Arizona), K M Johnson(Mayo Clinic), T. Grube, Mark J Donaldson(Mayo Clinic)
Cited by 133
Related Papers
The Somatic Genomic Landscape of Glioblastoma
|Cell|2013|5.2k
Tumor-associated B7-H1 promotes T-cell apoptosis: A potential mechanism of immune evasion
|Nature Medicine|2002|5.1k
Erratum: Tumor-associated B7-H1 promotes T-cell apoptosis: A potential mechanism of immune evasion
|Nature Medicine|2002|548
Genetic variants near <i>TIMP3</i> and high-density lipoprotein–associated loci influence susceptibility to age-related macular degeneration
|Proceedings of the National Academy of Sciences|2010|518